Xmet Inc (XMTTF) 0.0115 $XMTTF IIROC Trade Halt - Xmet

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Xmet Inc (XMTTF) 0.0115 $XMTTF

IIROC Trade Halt - Xmet Inc.
Newsfile Corp - Wed Jun 22, 12:12PM CDT
The following issues have been halted by IIROC:

Xmet Provides a Year End Update
Marketwired - Fri Nov 27, 11:13AM CST
Xmet Inc. ("Xmet" or the "Corporation" (TSX VENTURE: XME) is pleased to provide a year end update on the status of the Company and its properties.
XME.VN: 0.010 (unch)

4D Virtual Space Terminates Hearst WestZen Claim Option and Joint Venture With Xment Inc.
Marketwired - Fri Nov 06, 10:27AM CST
4D Virtual Space ("4DVS" or the Company" (CSE: ABJ) announces that it has terminated its Hearst WestZen claim option and Joint Venture with Xmet Inc.

BUYINS.NET: UXI, TX, XSD, SWI, XME, HOMB Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Nov 02, 7:34AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ProShares Ultra Industrials (NYSE:UXI), Tuckamore Capital Management Inc (NYSE:TX), Spdr S&P Semiconductor Etf (NYSE:XSD), SolarWinds Inc (NYSE:SWI), Xmet Inc (NYSE:XME), Home BancShares Inc (NASDAQ:HOMB) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
HOMB: 21.51 (-0.01), SWI: 59.98 (unch), UXI: 43.90 (unch), TX: 21.94 (-0.18), XME: 27.57 (-0.22), XSD: 49.57 (-0.37)

Xmet Announces Results of Its Annual Shareholders Meeting
Marketwired - Wed Aug 05, 3:50PM CDT
Xmet Inc. ("Xmet" or the "Corporation" (TSX VENTURE: XME) announces that its annual meeting was held on July 28, 2015. All directors were re-elected, the appointment of auditors was approved, the company's stock option plan was approved for the ensuing year and Xmet's Board of Directors proposal for a share consolidation should the need arise in connection with a possible future financing or acquisition was also approved as described in the Information Circular.
XME.VN: 0.010 (unch)

BUYINS.NET: AREX, REXX, IEO, XME, XOP, GMO Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Fri Jul 17, 6:41AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Approach Resources Inc (NASDAQ:AREX), Rex Energy Corp (NASDAQ:REXX), ishares Dow Jones US Oil and Gas Exploration and Production Index Fund (NYSE:IEO), Xmet Inc (NYSE:XME), Canadian Overseas Petroleum Ltd (NYSE:XOP), General Moly Inc (NYSE:GMO) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
GMO: 0.32 (unch), XOP: 36.85 (+0.06), REXX: 0.61 (unch), XME: 27.57 (-0.22), IEO: 59.43 (+0.17), AREX: 2.70 (+0.09)

Xmet Announces Mailing of Notice of Meeting and Management Information Circular for July 28, 2015 Annual Shareholders Meeting
Marketwired - Tue Jul 07, 3:00PM CDT
Xmet Inc. ("Xmet" or the "Corporation" (TSX VENTURE: XME) announces that it has mailed the Notice of Meeting and Management Information Circular in connection with its Annual and Special Meeting of Shareholders scheduled for July 28, 2015 (the "Meeting". At the Meeting the Meeting, Xmet will propose the re-election of Alexander Stewart, Stephen Stewart, Jean-Pierre Colin, Charles Beaudry, Sam Garofalo and Matey Nedkov de La Camp as directors, the re-appointment of Parker & Simone LLP as auditors, the approval of the Corporation's stock option plan and the receipt of the Corporation's annual audited financial statements. Also in connection with the Meeting, the board of directors of Xmet (the "Board" also announces that it is proposing that shareholders authorize the directors to complete a share consolidation should the need arise in connection with a possible future financing or acquisition. Xmet is not proposing to undertake a consolidation at this time, but rather that shareholders provide authorization for the board to have flexibility to do so in the future. The consolidation would be authorized on the basis of one post-consolidation common share for each 1.25 to 10 pre-consolidation common shares, with such ratio to be determined by the board with a view to ensuring a minimum share price of $0.05 per share post-consolidation. Based on 114,982,049 common shares currently issued and outstanding, the consolidation would result in there being outstanding approximately 11,498,205 common shares (if a 10:1 consolidation) and 91,985,639 common shares (if a 1.25:1 consolidation). Such authorization is subject to shareholder approval at the Meeting to be held July 28, 2015 as well as approval of the TSX Venture Exchange. In the event of a consolidation, Xmet is not proposing to change its name.
XME.VN: 0.010 (unch)

Metals Creek Resources Update on the Blackflake West Option
Marketwired - Fri Jun 19, 3:16PM CDT
Metals Creek Resources Corp. (TSX VENTURE: MEK) (the "Company" has been advised by Xmet Inc. (TSX VENTURE: XME) that the Blackflake West drill campaign confirmed the existence of an extensive Volcanogenic Massive Sulphide system with wide zones of mineralized rock. Assay results from the detailed sampling along the four holes confirms the anomalous base metal and gold values obtained in the rush sampling. The El Gordo target returned a maximum of 0.34%Zn over 4.0 metres in siliceous metamorphosed rhyolite with sulphide stringers and the El Nino target returned a maximum of 0.36%Zn and 503ppm Cu over 3.0 metres in semi massive to massive sulphide. Xmet management is reviewing the data from the project, specifically the lithogeochemical sample results in order to decide the next steps to be taken on the project. The data received from the drill program and its subsequent testing will be further evaluated given the presence of a Volcanogenic Massive Sulphide system as opposed to a hydrothermal graphite occurrence. Xmet has spent the necessary funds to retain its option in good standing through May of 2017.
XME.VN: 0.010 (unch), MEK.VN: 0.115 (+0.005)

Xmet Updates on Win-Win, Blackflake West and Grasset Projects
Marketwired - Fri Jun 19, 3:01PM CDT
Xmet Inc. ("Xmet" or the "Company" (TSX VENTURE: XME) is pleased to provide updates for its three current Projects, the Win-Win, Blackflake West and Grasset.
XME.VN: 0.010 (unch)

Xmet Options 100% of Win-Win Project Adjacent to and along strike to IAMGold's Monster Lake
Marketwired - Mon May 11, 8:15AM CDT
Xmet Inc. ("Xmet" or the "Company" (TSX VENTURE: XME) is pleased to announce that it has acquired a 100% option on the Win-Win Project located 35 kms southwest of the town of Chibougamau, Quebec. The Win-Win Project is adjacent to and immediately north of the IAMGold and TomaGold project called Monster Lake. In November 2013 IAMGold optioned a 50% interest in the Monster Lake Project in return for an investment of $17.575 million over a five year period. The agreement is subject to approval of the TSX Venture Exchange (the "Exchange". See Figure 1 below for Map of Xmet's Win-Win claims.
XME.VN: 0.010 (unch)

Xmet Closes $253,000 Financing by Way of Debt Conversion
Marketwired - Fri May 01, 3:01PM CDT
Xmet Inc. ("Xmet" or the "Company" (TSX VENTURE: XME) is pleased to announce that it has issued today to certain of its arm's length creditors, 5,060,000 units of the Company in satisfaction of aggregate indebtedness of $253,000 at an effective price of $0.05 per unit. Each unit is comprised of one common share of Xmet and one common share purchase warrant of Xmet. Each warrant entitles the holder to acquire one common share of Xmet at a price of $0.05 at any time until May 1, 2020.
XME.VN: 0.010 (unch)

Xmet Completes Initial Diamond Drill Program on Grasset Project
Marketwired - Thu Apr 09, 7:03AM CDT
Xmet Inc. ("Xmet" or the "Company" (TSX VENTURE: XME) is pleased to report that it has completed the initial phase of the diamond drilling program on its wholly-owned Grasset Property, located along the eastern extension of the Detour-Sunday Lake deformation zone in the highly prolific Abitibi Mining District of Quebec.
XME.VN: 0.010 (unch)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vipshop Prepares for Q3 Financial Results Release

Updated Category News Views 60

Countdown to Vipshop's Third Quarter Results November 24th might just be another day on the calendar for some, but for those of us keeping tabs on the markets, it's a make-or-break moment for Vipshop Holdings Limited. The off-price retail titan from China, trailing under the ticker NYSE:VIPS, is gearing up to swing the doors wide open on its third-quarter financial...

Continue Reading
Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 19

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
HearUSA Expands Access with AI-Powered Hearing Aids

Updated Category News Views 24

AI Revolution in Hearing Care Look, the hearing aid industry isn't known for headlines that grab you by the throat, but HearUSA just tossed a proverbial grenade into the scene with Widex Allure AI RIC. This is more than a slight tweak in hearing tech—it's a game-changer. We're talking about on-demand AI noise management blended with Widex's renowned natural sound. It's...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 139

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
YYForce's Strategic Play: Robotics and AI Expansion

Updated Category News Views 11

Innovation Meets Pragmatism at YYForce There's a new bout of excitement brewing over at YYForce Inc. (NASDAQ: YFOR), if the latest announcements are anything to go by. The Singapore-based AI-enabled workforce dynamo is laying out priorities like a general plotting a campaign—pragmatic, strategic, and with a keen eye on the bottom line. Aiming for a Technological Edge In...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 150

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 254

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CureGene's CG-0416: Promising Weight Loss Breakthrough

Updated Category News Views 94

Game-Changer in Weight Management? Oh, the obesity world is buzzing, folks! There's some big noise coming from CureGene, and it's catching the attention of every lab-coat smarty in town. They just tossed out some preclinical data on CG-0416 at Obesity Week 2026 that could shake up how we tackle weight loss. Anyone still clinging to their old diet books might want to take...

Continue Reading
Asia-Pacific Miracle: New Economic Chapter Unfolds

Updated Category News Views 31

A Fresh Breeze in Asia-Pacific's Sails You ever look around and realize everything's about to change—again? That's Asia-Pacific right now. We're staring down the barrel of a new chapter in what folks are calling the "Asia-Pacific miracle." The text from China Daily paints a picture of a region gearing up to crank the cooperation dial even higher. And where's this...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 343

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

BitGo Faces Securities Fraud Suit Amid Investor Losses

Updated Category News Views 69

BitGo's Legal Woes: A Deep Dive into the Allegations A lawsuit can shake up a company's foundations, and BitGo Holdings, Inc. (NYSE: BTGO) is feeling the heat right now. The focus of this busy investor morning isn’t some penny stock drama; we're talking about players in the digital asset game accused of pulling the wool over investors' eyes. Slap on those reading...

Continue Reading
Investors Alert: Deadline Approaches in Match Group Lawsuit

Updated Category News Views 141

Important Deadline Approaching for Match Group Investors Recently, there has been a notable reminder for investors concerning a class action lawsuit involving Match Group, Inc. (NASDAQ: MTCH). The law firm Glancy Prongay & Murray LLP has highlighted that all individuals who purchased shares in Match Group during the specified period should be aware of the upcoming...

Continue Reading
Leadership Transition at Coloplast A/S: New Era Begins

Updated Category News Views 937

Coloplast A/S Announces Leadership Change In a significant shift for Coloplast A/S, CEO Kristian Villumsen has officially stepped down. Today marks the start of a new chapter as the Board of Directors mobilizes Lars Rasmussen to serve as interim CEO while the search for a permanent replacement is conducted. Strategic Shift for the Future This change comes at an opportune...

Continue Reading
Johnson & Johnson's Strong Q3 Results Amid Market Declines

Updated Category News Views 109

Market Overview On a day marked by declining values, U.S. stocks experienced a noticeable downturn. The Nasdaq Composite index saw a drop of around 150 points, indicating a challenging market environment. As trading progressed, the Dow Jones Industrial Average slipped slightly, and the S&P 500 also followed suit, showing varied performance across sectors. Sector...

Continue Reading
Moroccanoil Expands Product Line at Ulta Beauty Nationwide

Updated Category News Views 204

Moroccanoil Expands Product Line at Ulta Beauty Nationwide Moroccanoil is thrilled to announce an exciting partnership with Ulta Beauty, the premier beauty retailer in the nation. This significant expansion reaffirms Moroccanoil's commitment to delivering high-quality beauty products to a wider audience while honoring its legacy rooted in the salon community. Launching at...

Continue Reading